Capital Impact Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Capital Impact Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-63,403	Closed	-$1.27M	–	159
2017 Q4	$1.27M	Hold	63,403	–	–	0.55%	95
2017 Q3	$1.31M	Buy	63,403 +14,465	+30%	+$245K	0.59%	86
2017 Q2	$724K	Sell	48,938 -18,748	-28%	-$312K	0.33%	142
2017 Q1	$1.08M	Buy	67,686 +34,918	+107%	+$504K	0.43%	125
2016 Q4	$413K	Hold	32,768	–	–	0.17%	207
2016 Q3	$918K	Hold	32,768	–	–	0.4%	127
2016 Q2	$1.15M	Hold	32,768	–	–	0.54%	48
2016 Q1	$898K	Hold	32,768	–	–	0.43%	126
2015 Q4	$1.12M	Hold	32,768	–	–	0.54%	48
2015 Q3	$941K	Hold	32,768	–	–	0.48%	62
2015 Q2	$1.47M	Hold	32,768	–	–	0.67%	34
2015 Q1	$1.13M	Buy	+32,768	New	+$892K	0.52%	52

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Capital Impact Advisors's DPLO Position: Q1 2018 in Review

Capital Impact Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 63,403 shares — an estimated $1.27M sold.

Capital Impact Advisors first reported a position in DPLO in Q1 2015 and held it in 12 quarters. The position peaked at $1.47M in Q2 2015. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

Capital Impact Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
Capital Impact Advisors sold 63,403 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $1.27M.
Capital Impact Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 12 quarters.
Capital Impact Advisors's DIPLOMAT PHARMACY, INC. position peaked at $1.47M in Q2 2015.
201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Capital Impact Advisors's 13F filing for Q1 2018, filed 11 Apr 2018.